Cetuximab Plus RT Not Ready for Prime Time in Laryngeal CancerCetuximab Plus RT Not Ready for Prime Time in Laryngeal Cancer

Outcomes favor cetuximab plus radiotherapy vs radiotherapy alone in laryngeal cancer, even though results are not statistically significant. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news